Clinical Usefulness of delta MELD to Predict the Survival of Patients with Liver Cirrhosis / 대한간학회지

<0.001) compared with 0.575 for MELD score and 0.636 for CP score at 6 month-mortality; the area was 0.727, 0.594 and 0.657 at 12 month-mortality; 0.693, 0.587 and 0.639 at 24 month-mortality, respectively. The patients with delta MELD/month more than 1.0 had resulted in the higher mortality at 6, 12 and 24 months. The delta MELD/month was associated with mortality and was an independent prognostic predictor with a risk ratio of 1.679 (95% CI: 1.381-2.042, P<0.001). CONCLUSIONS: Determination of delta MELD could be better prognostic predictor for patients with liver cirrhosis than initial MELD and CP score.